Scaled Average Methodology
Scaled Average Methodology is a statistical approach in bioequivalence assessment that, as a member of the broader class of average bioequivalence methods, uniquely incorporates the within-subject variability of the reference product to scale the equivalence limits, thereby accommodating highly variable drugs or drug products.
15
Publications
560
Citations
47
Authors
24
Institutions
Publications per year
2017–2026
4
15
1–5 of 15
47
5
h-index
4
h-index
1
h-index
1
h-index
1
h-index
1–5 of 47
24

University of Toronto
Toronto, Canada
5 h-index
5 publications
158 citations
Semmelweis University
Budapest, Hungary
4 h-index
4 publications
146 citations
AGH University of Krakow
Krakow, Poland
1 h-index
3 publications
36 citations
Pfizer (United States)
New York, United States
1 h-index
1 publications
13 citations

Kyoto University
Kyoto, Japan
1 h-index
5 publications
145 citations

University of Belgrade
Belgrade, Serbia
1 h-index
5 publications
80 citations
Canada Research Chairs
Ottawa, Canada
1 h-index
1 publications
25 citations
Amgen (United States)
Thousand Oaks, United States
1 h-index
3 publications
36 citations
1–8 of 24
3 publications · 115 citations
3
h-index
JPPS · 2 publications · 57 citations
2
h-index
1 publications · 13 citations
1
h-index
1 publications · 17 citations
1
h-index
AAPSJ · 1 publications · 25 citations
1
h-index
1–5